Quick summary: AG-Telmisartan tablet: Overweight & Underweight tablets. Date: 2024-09-09.
Public recall detail
AG-Telmisartan tablet: Overweight & Underweight tablets
2024-09-09
Recall
Safety notice
Quick summary
Recommended action
Recommended action: compare your product with the official notice and follow the instructions published by the official source.
Recall details
Quick summary: AG-Telmisartan tablet: Overweight & Underweight tablets. Date: 2024-09-09.
Official details
Affected product details
Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.
BrandAngita
ProductAG-Telmisartan 40 mg & 80 tablet
IssueHealth products - Product quality
Recall classType II
IdentificationRA-76021
Affected products
BrandAngita
ProductAG-Telmisartan 40 mg tablet
DIN / NPN / authorizationDIN 02484536
Dosage formTablet
StrengthTelmisartan 40 mg
LotEG23AGI001, EG23AGI002, EG23AGI003, EG23AGD001, EG23AGD002, EG23AGD003
BrandAngita
ProductAG-Telmisartan 80 mg tablet
DIN / NPN / authorizationDIN 02484544
Dosage formTablet
StrengthTelmisartan 80 mg
LotEG22AGE002, EG23AGE001, EG23AGE002, EG23AGE004, EG23AGE005, EG23AGJ001, EG23AGJ002, EG23AGJ003
Issue
Affected lots may contain overweight or underweight tablets.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional official information
AudienceGeneral public Healthcare Industry
CategoryHealth products - Drugs
CompaniesANGITA PHARMA INC. 1310 Rue Nobel, Boucherville, QC J4B 5H3
Published byHealth Canada
Recall classType II
Alert / recall typeHealth product recall
Identification numberRA-76021
Background{}
CompaniesANGITA PHARMA INC. 1310 Rue Nobel, Boucherville, QC J4B 5H3
AudiencesGeneral public Healthcare Industry
Source updated2024-09-09
Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.
FAQ
Frequently asked questions
Answers based on the official recall notice.
Product images
Official product images from Health Canada.
Starting...
Explore more
Related recalls
Similar recalls and safety notices.